|Articles|December 1, 2002
New enterprise: Nutraceutical company launches new products
Lexington, SC-A new research-based, ophthalmic nutraceutical company founded by one of the leading ophthalmologists in the United States has launched its line of nutraceutical products to optimize eye and body health.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5











































.png)


